Karyopharm Therapeutics
KPTI
KPTI
119 hedge funds and large institutions have $738M invested in Karyopharm Therapeutics in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
8% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 37
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
68% less call options, than puts
Call options by funds: $1.14M | Put options by funds: $3.56M
Holders
119
Holding in Top 10
1
Calls
$1.14M
Puts
$3.56M
Top Buyers
| 1 | +$10.1M | |
| 2 | +$8.09M | |
| 3 | +$5M | |
| 4 |
BlackRock
New York
|
+$3.49M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$2.89M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$6.76M | |
| 3 | -$5.15M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$4.48M |
| 5 |
Goldman Sachs
New York
|
-$3.9M |